Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tocilizumab and adalimumab in an 18q deletion syndrome patient with chronic arthritis.

Clinical and experimental rheumatology - 1 Jan 2000

Kashima Soki, Tsuchida Satoko, Koizumi Hiromi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adalimumab
Share to Antibodies, Monoclonal, Humanized
Share to Antirheumatic Agents
Share to Arthritis, Juvenile

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Deletion

Share to Chromosome Disorders

Share to Chromosomes, Human, Pair 18

Share to Drug Substitution

Source

Identifiers

PMID: 25665051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Tocilizumab and adalimumab in an 18q deletion syndrome patient with chronic arthritis.PMID 25665051Read ↗

Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome.Semantic proximity Read ↗

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.Semantic proximity Read ↗

Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms.Semantic proximity Read ↗

Deficiency of the interleukin-36 receptor antagonist dramatically improved by secukinumab.Semantic proximity Read ↗

Rheumatoid arthritis in an adult patient with mosaic distal 18q-, 18p- and ring chromosome 18Semantic proximity Read ↗

Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome.Semantic proximity Read ↗

The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.Semantic proximity Read ↗

A Complex Infectious, Inflammatory, and Autoimmune Phenotype Reveals 22q11.2 Deletion Syndrome in an Adult.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.